The bidding window for Pushpa Jewellers SME IPO was open from June 30, 2025, to July 2, 2025. The IPO received 1,36,51,000 bids against 67,11,000 total shares offered.
The basis of allotment will be finalised today, July 3, 2025. Here’s how you can check the IPO allotment status.
Click here to explore other Upcoming IPOs
Pushpa Jewellers IPO is a book-building issue of ₹98.65 crores, consisting of a fresh issue of ₹78.94 crores and an Offer For Sale component of ₹19.71 crores. The price band is set at ₹143 to ₹147 per share. The tentative listing on NSE Emerge is July 7, 2025.
Affinity Global Capital Market Private Limited is the book-running lead manager, and Cameo Corporate Services is the registrar for the issue.
The net proceeds from the fresh issue will be used to
Click here to check out newly Listed IPOs
(July 2, 2025, end of the day)
Category |
Subscription (times) |
Qualified Institutional Investors (QIBs) |
1.18 |
Non-Institutional Investors |
2.51 |
Retail Individual Investors(RIIs) |
3.71 |
Total |
2.46 |
As of 3 July 2025, Pushpa Jewellers' IPO’s GMP stood at nil. The shares are expected to list at par with the issue price of ₹147.
Source: Business Standard Report dated 3 July, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Pushpa Jewellers specialises in crafting and supplying an exquisite range of Traditional and Contemporary Gold Jewellery. Currently, they operate from three key office-cum-showroom locations in Hyderabad, Bangalore, and Chennai and are actively planning to expand their footprint with additional branches in strategic cities like Vijayawada.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here